Pharmaceutical

EMA CHMP issues positive opinion for AstraZeneca’s Soliris

The EMA CHMP has issued a positive opinion recommending marketing authorisation for expanded use of AstraZeneca’s Soliris (eculizumab).

Jun 27, 2023 - 20:00
EMA CHMP issues positive opinion for AstraZeneca’s Soliris
The EMA CHMP has issued a positive opinion recommending marketing authorisation for expanded use of AstraZeneca’s Soliris (eculizumab).
Read the original article

Tags:

Previous Article

Wane in Covid demand hurts Walgreens as profits drop to $118m

Next Article

Inflation reduction act boosts biologic drug venture financing over small molecules

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Related Posts

STAT+: Pear Therapeutics sold for parts at $6 million auction

STAT+: Pear Therapeutics sold for parts at $6 million a...

May 19, 2023

FDA approves US WorldMeds’s iwilfin for neuroblastoma

FDA approves US WorldMeds’s iwilfin for neuroblastoma

Dec 16, 2023

STAT+: Q&A: Sen. Sanders on insulin costs and his committee’s generic drug kerfuffle

STAT+: Q&A: Sen. Sanders on insulin costs and his commi...

May 9, 2023